Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups BayStreet.ca - Thu Jul 10, 2025

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent CDC data...

ONCY : 0.7938 (-0.79%)
INAB : 1.1250 (-5.46%)
ONC.TO : 1.42 (+2.16%)
TNGX : 26.02 (-2.62%)
MBIO : 0.6339 (+13.20%)
ELVN : 53.05 (+0.59%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies FinancialNewsMedia - Tue Jul 8, 2025

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MBIO),(NASDAQ:VSTM),(NASDAQ:CRDF),(NASDAQ:AZN) EQNX::TICKER_END

ONCY : 0.7938 (-0.79%)
AZN : 172.06 (+1.43%)
ONC.TO : 1.42 (+2.16%)
VSTM : 6.09 (+0.16%)
CRDF : 0.8112 (-2.95%)
MBIO : 0.6339 (+13.20%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies GlobeNewswire - Tue Jul 8, 2025

ONCY : 0.7938 (-0.79%)
AZN : 172.06 (+1.43%)
ONC.TO : 1.42 (+2.16%)
VSTM : 6.09 (+0.16%)
CRDF : 0.8112 (-2.95%)
MBIO : 0.6339 (+13.20%)
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma GlobeNewswire - Mon Jul 7, 2025

FBIO : 3.29 (+0.61%)
MBIO : 0.6339 (+13.20%)
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement GlobeNewswire - Wed Mar 5, 2025

FBIO : 3.29 (+0.61%)
MBIO : 0.6339 (+13.20%)
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility GlobeNewswire - Thu Feb 27, 2025

MBIO : 0.6339 (+13.20%)
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire - Tue Feb 11, 2025

MBIO : 0.6339 (+13.20%)
Mustang Bio Announces Closing of $8 Million Public Offering GlobeNewswire - Mon Feb 10, 2025

MBIO : 0.6339 (+13.20%)
Mustang Bio Announces Pricing of $8 Million Public Offering GlobeNewswire - Thu Feb 6, 2025

MBIO : 0.6339 (+13.20%)
Mustang Bio Announces Reverse Stock Split GlobeNewswire - Tue Jan 14, 2025

MBIO : 0.6339 (+13.20%)

Barchart Exclusives

Stay Away from Etsy Stock Now Despite Shares Hitting a New 2-Year High. Short Sellers Are in Control. Barchart - 11 minutes ago
Etsy (ETSY) demonstrates strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. Shares are up 36% over the past year and recently hit a new 2-year high. ETSY’s fundamentals show flat revenue projections for the next two years, but earnings are estimated to rebound significantly High short interest also... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.